Appendix Table B. Medication Codes to Identify Immunocompromising Conditions for Assessment of Risk
Condition (Code Type)Code(s) or Drug Category / Description
HIV (NDCs, HCPCS)
Abacavir sulfate
Abacavir sulfate/lamivudine
Abacavir sulfate/lamivudine
Amprenavir/vitamin E
Atazanavir sulfate
Darunavirethanolate
Delavirdinemesylate
Didan/calcium carb/magnesium
Didan/mag salt/al nacb/sod cit
S0137 / Didanosine
Efavirenz
Efavirenz/emtricitab/tenofovir
Emtricitabine
Emtricitabine/tenofovir
J1324 / Enfuvirtide
Etravirine
Fosamprenavir calcium
Indinavir sulfate
Lamivudine
Lamivudine/zidovudine
Lopinavir/ritonavir
Maraviroc
Nelfinavirmesylate
Nevirapine
Raltegravir potassium
Ritonavir
Ritonavir/lopinavir
S0140 / Saquinavir
Stavudine
Tenofovirdisoproxilfumarate
Tipranavir
Zalcitabine
J3485 / Zidovudine
Zidovudine/lamivudine
Malignant neoplasms (NDC, HCPCS)
Alkylating agents / Bendamustine, Busulfan, Carmustine, Carmustine/polifeprosan, Chlorambucil, Cyclophosphamide, Dacarbazine, Estramustine, Ifosfamide, Lomustine, Mechlorethamine, Melphalan, Procarbazine, Streptozocin, Temozolomide, Thiotepa, Uracil mustard
Platinum agents / Carboplatin, Cisplatin, Oxaliplatin
Antimetabolites / Antifolate: Methotrexate, Pemetrexed
Purine antagonist: Cladribine, Clofarabine, Cytarabine, Fludarabine, Mercaptopurine, Nelarabine, Pentostatin, Thioguanine
Pyrimidine:Azacitidine
Pyrimidine Antagonist:Capecitabine, Floxuridine, Fluorouracil, Gemcitabine
Miscellaneous:Hydroxyurea
Antimicrotubule agents / Taxanes: Docetaxel, Paclitaxel, Albumin-bound paclitaxel
Vinca alkaloids: Vinblastine, Vincristine, Vinorelbine
Epothilone analog: Ixabepilone
Topoisomerase-active agents / Topoisomerase I inhibitors:Irinotecan, Topotecan
Topoisomerase II inhibitors:Daunorubicin, Doxorubicin, Pegylated liposomal doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin, Etoposide
Podophyllotoxins / Teniposide
Antineoplastic antibiotic / Bleomycin, Dactinomycin, Mitomycin C, Plicamycin
Endocrine agents / Androgen:Testolactone, Fluoxymesterone
Antiandrogens:Bicalutamide, Flutamide, Nilutamide
Aromatase inhibitors:Aminoglutethimide, Anastrozole, Exemestane, Letrozole
Estrogen receptor antagonists:Raloxifene, Tamoxifen, Toremifene, Fulvestrant
GnRH agonists:Histrelin, Triptorelin
LNRH agonists:Goserelin, Leuprolide
LNRH antagonist:Abarelix
Progestins:Medroxyprogesterone, Megestrol
Estrogens: Diethylstilbestrol (DES), Ethinyl estradiol
Biologically-directed therapies / Molecular targets:Alitretinoin, Bexarotene, Bortezomib, Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Nilotinib, Sorafenib, Sunitinib, Temsirolimus, Tretinoin
Monoclonal antibodies:Alemtuzumab, Bevacizumab, Cetuximab, Gemtuzumab, Ibritumomab, Panitumumab, Rituximab, Tositumomab, Trastuzumab
Immune therapies / Aldesleukin (IL-2), Interferon alfa-2a, Interferon alfa-2b, Lenalidomide, Thalidomide
Misc agents / Altretamine, Arsenic trioxide, Asparaginase, BCG vaccine, Decitabine, Denileukin, Levamisole, Mitotane, Pegaspargase, Porfimer, Strontium-89, Zoledronic acid, Vorinostat
Organ transplantation (NDC, HCPCS)
J7500, J7501 / Azathioprine
J7502, J7515, J7516 / Cyclosporine
J7507, J7525, 80197 / Tacrolimus anhydrous
M7517 / Mycophenolatemofetil
J7520 / Sirolimus
J7518 / Mycophenolate sodium
Tacrolimus, micronized
J7505 / Muromonab-CD3
J7513 / Daclizumab
J0480 / Basiliximab
J7599 / Immunosuppressive drug, not otherwise classified